The aim of the study was to compare three anaesthetic agents in patients with ejection fraction below 0.40 subjected to coronary revascularization surgery. Twenty-five elective coronary surgical patients with ejection fraction below 0.40 were prospectively studied. Premedication was pethidine 1 mg/kg and induction was fentanyl 0.03 mg/kg and pancuronium 0.1 mg/kg. The patients were randomized to one of three maintenance techniques (fentanyl, isoflurane or halothane).
Anaesthetic management of patients with impaired ventricular function undergoing coronary revascularization is complicated by their diminished cardiovascular reserve. Adaptation to major surgical trauma, anoxic cardioplegia, depressant effects of anaesthesia and haemodilution may also be altered.
Recently, there has been renewed interest in the use of inhalational anaesthetics for cardiac surgery [1] [2] [3] [4] [5] , because of their shorter recovery time and potential to decrease costs. All inhalational agents, however, depress myocardial contractility and are generally avoided in patients with diminished ventricular function. Isoflurane is stated to produce less myocardial depression and more vasodilation than halothane [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] , and may be considered a preferable alternative in this situation.
In spite of the many reports comparing anaesthesia techniques [1] [2] [3] [4] [7] [8] [9] 13, [16] [17] [18] [19] [20] [21] , there are few comparisons in patients with decreased ventricular function 1, 3, 4 . Additional information is required to rationally manage these patients. Therefore, we compared halothane, isoflurane and fentanyl in patients with decreased left ventricular ejection fraction undergoing elective coronary revascularization.
METHODS
This study was conducted under institutional approval by the Research Ethics Review Comittee of the Catholic University of Chile School of Medicine.
All patients 50 to 70 years old scheduled for firsttime elective myocardial revascularizaton, with a preoperative ejection fraction below 0.4, were included. Organ dysfunction, re-operations, combined procedures, myocardial infarction less than one week, haemodynamic instability, or anginal pain on arrival in the operating room were causes for exclusion.
Left ventricular ejection fraction was measured in all cases by the same cardiologist (RG), from the preoperative contrast ventriculography, using the Dodge's two-projection planimetric technique. He was not aware as to the anaesthesia technique or haemodynamic findings.
All patients received flunitrazepam 2 mg the night before surgery and pethidine 1 mg/kg one hour before induction. Drug therapy for angina and hypertension was maintained up to the morning of surgery. On arrival in the operating room, each patient was assigned to one of the three study groups (fentanyl, halothane, or isoflurane) by means of a random number generator.
Induction of anaesthesia in all patients consisted of fentanyl 0.03 mg/kg and pancuronium 0.1 mg/kg, injected intravenously over two to three minutes. Patients randomized to inhalational agents received in addition halothane 1% or isoflurane 1.5%, respectively, by mask. The trachea was intubated two to four minutes later. Between 650 and 1000 ml of Hartmann's solution were infused during that period.
Maintenance of anaesthesia excluded the use of any anaesthetic agent other than the one allocated. Patients randomized to fentanyl were ventilated with 100% oxygen. As maintenance of anaesthesia they received supplemental doses of 0.5 mg fentanyl before sternotomy, before and during cardiopulmonary bypass, and before sternal closure, plus additional doses if systolic blood pressure increased over 120 mmHg or heart rate above 90 b/min. Patients randomized to inhalational agents received concentrations not exceeding 1.5% halothane or 2% isoflurane in oxygen, respectively. The attending anaesthetist aimed to maintain systolic arterial blood pressure in the 100 to 120 mmHg range by adjusting the concentration of inhalational agent and by volume infusion. Halothane 0.7% or isoflurane 1%, respectively, was vaporized into the oxygenator during cardiopulmonary bypass. In all groups, a supplemental dose of 4 mg pancuronium was given during rewarming.
Vasoconstrictor, vasodilator, or inotropic agents were avoided until the post-sternotomy measurements had been collected. If hypotension before sternotomy could not be controlled by decreasing concentration of inhalational agent and volume infusion, then it was to be treated with ephedrine, calcium chloride, and head-down position. In that case, no measurements would be taken until the effect of the therapy had subsided. If haemodynamic support was required after sternotomy, then it was to be discontinued during bypass and restarted only after post-bypass measurements had been obtained. Sodium nitroprusside was used intra-or postoperatively if systolic arterial pressure exceeded 140 mmHg in spite of additional anaesthetic. To minimize operator-dependent variability, the same anaesthetist (JU) was present in all cases, either as attending (14 cases), or collecting data. No attempt was made to blind the attending anaesthetist as to the anaesthetic agents or hemodynamic measurements. In all cases, data was collected by an anaesthetist other than the attending.
Monitoring included rectal and oesophageal temperatures, urine output, D2 and V5 electrocardiogram, radial arterial pressure, pulmonary arterial pressure, right atrial pressure and thermodilution cardiac output. Catheters were inserted before induction of anaesthesia. Cardiac output was measured as the average of three injections with acceptable dilution curves, or two injections if they diverged by less than 5%.
Extracorporeal circulation was performed utilizing a disposable oxygenator (BIO-10å, Bentley Laboratories, Irvine, CA, U.S.A.), primed with 1.5 l of lactated Ringer's solution. Patients were haemodiluted to 20 to 22% haematocrit and transfusion of bank blood was avoided. Hypothermia to 25°C was utilized in all cases. Perfusion flow was maintained at 2.2 l/min/m 2 throughout bypass, mannitol 50 to 75 g was added to the oxygenator to promote diuresis. Acid-base disturbances were corrected using α-Stat.
Myocardial preservation consisted of topical cooling of the heart with ice slush and 700 to 1800 ml cold St Thomas cardioplegic solution injected into the aortic root.
Revascularization was performed using the left internal mammary artery, plus one to four saphenous vein grafts.
Weaning from cardiopulmonary bypass was attempted first without inotropic support and a set of measurements obtained. If haemodynamics were unsatisfactory, then appropriate inotropic support was established.
Radial arterial pressure, heart rate, right atrial, pulmonary arterial and occluded pressures and thermodilution cardiac output were measured, and cardiac index and systemic vascular resistance calculated, at the following times. 1. Before induction of anaesthesia; 2. Five minutes after endotracheal intubation; 3. Two minutes after sternotomy; 4. Immediately after discontinuation of cardiopulmonary bypass; 5. Fifteen minutes after bypass; 6. Immediately after sternal closure; 7. During suture of the skin; 8. Five minutes after arrival in the postoperative care unit; and 9. 60 minutes postoperatively.
Unless specified otherwise, results are presented as mean with standard deviation in parenthesis. Sequential changes within each group were analyzed by repeated measurements analysis of variance with the Student-Newman-Keuls test. Differences between groups for haemodynamic variables were determined by two-way analysis of variance for multiple comparisons. Single variables between groups were compared by analysis of variance, Chisquared test, or Fisher exact test where appropriate. Statistical significance was <0.05.
RESULTS
Twenty-five patients, 24 of them male, were included in the study. Twelve patients (four in each group) had one or more prior episodes of myocardial infarction. All were receiving beta or calcium channel blockers, but none angiotensin converting enzyme inhibitors. The groups were comparable as to age, body surface area, number of grafts, preoperative left ventricular ejection fraction, duration of extracorporeal circulation and duration of anoxic cardiac arrest ( Table 1) .
All patients completed their operations without the need to deviate from the anaesthesia maintenance technique specified in the protocol. Concentration of inhalational agents was frequently varied and com-plete interruption of their administration was often needed to secure systolic pressure above 100 mmHg. There were no instances of hypotension that required additional therapy before sternotomy. Intraoperative use of inotropes and vasodilators, presence of clinically obvious ischaemic ST segment alterations, postoperative enzyme elevation, and duration of hospital stay are presented in Table 2 .
Haemodynamic measurements are presented in Figures 1 and 2 . Mean arterial pressure following induction did not significantly differ from control in the fentanyl group; however, it decreased significantly in the isoflurane group and nonsignificantly in the halothane group. The difference between fentanyl and the two other agents reached statistical significance after induction, but there were no differences after sternotomy (Figure 1 ). Mean arterial pressure was significantly decreased following cardiopulmonary bypass in all groups and gradually increased afterwards.
Following induction, cardiac index decreased significantly in the isoflurane group and nonsignificantly in the halothane group. The difference between isoflurane and fentanyl was statistically significant following sternotomy. After cardiopulmonary bypass, cardiac index was not significantly different from control or between groups (Figure 1 ).
Both isoflurane and halothane patients showed increased systemic vascular resistance following sternotomy. This was more pronounced for isoflurane being significantly higher than fentanyl. Following discontinuation of cardiopulmonary bypass, systemic vascular resistance decreased significantly in all patients; there were no differences between groups. Cardiac index remained close to control values, but arterial blood pressure was significantly decreased compared with control. There were no differences between groups. Resistance gradually increased afterwards, reaching significantly elevated values postoperatively. There were no further significant differences between groups (Figure 1 ). 581 
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Surgery was successfully completed in all cases. The patients were sedated and mechanically ventilated overnight. None required intra-aortic balloon counterpulsation. There was no perioperative mortality or postoperative morbidity that could be causally connected to the anaesthesia technique. There were no instances of intraoperative awareness.
DISCUSSION
Comparing anaesthesia techniques in patients is generally fraught with difficulties, both during data collection and later when interpreting the results. If the patients belong to a high-risk group, as is the case in our study, this becomes even more pronounced. Ethical considerations prevent blinding the anaesthesiologist to the anaesthetic agents and haemodynamic data, drug doses cannot be rigidly preestablished, therapeutic intervention cannot be precluded, and inter-individual variability exceeds what is desirable for meaningful statistics. Nevertheless, clinical studies such as this are necessary as they provide the clinician with information that cannot be gathered from healthy volunteers or from lower risk patients. In effect, haemodynamic responses of sicker patients may differ from those of healthy subjects, and anaesthetic agents and dosages 582 J. URZUA, M. SERRA ET AL Anaesthesia and Intensive Care, Vol. 24, No. 5, October 1996 well tolerated by young, healthy volunteers may produce significant derangement in older, sicker patients. Two findings in this study differ from the expected results and deserve further comment. The first is that patients in the isoflurane group showed increased systemic vascular resistance and decreased cardiac index following sternotomy. This was not expected, because isoflurane is a vasodilator and reportedly possesses less myocardial depressant effect than halothane 7, 8, 13, 14, 16, 17, [20] [21] [22] . Perhaps the myocardial depressant effect of isoflurane is less apparent in experimental subjects or more "normal" patients, but becomes more pronounced in patients with a sick heart. If this was the case, then the vasodilator effect of isoflurane may have been offset by the arterial pressure control mechanisms, which increase sympathetic vasoconstriction in response to hypotension. Thus, the extrapolation of pharmacologic data from healthy volunteers or more "normal" subjects to patients with abnormal cardiac function would be unwarranted.
It is not clear whether decreased cardiac index or increased resistance was primary. Decreased cardiac index may result from impaired contractility due to depressant effect of anaesthetics, decreased venous return due to venodilation, loss of negativity of intrathoracic pressure, hypovolaemia due to bleeding or preoperative fasting, and decreased oxygen consumption associated with inhalational anaesthesia. On the other hand, primary increases of vascular resistance are also possible, and may be due to light anaesthesia, cardiovascular reflexes originating in the heart or great vessels, endothelial dysfunction (increased endothelin or decreased nitric oxide) 22 , hypercarbia, endogenous vasoactive substances such as angiotensin or thromboxane, and exogenous vasoconstrictor drugs. We cannot exclude light anaesthesia, as we lack a reliable method of measuring anaesthetic depth. However, one would expect increased vascular resistance due to light anaesthesia to be associated with increased cardiac output, hypertension and tachycardia. This was not the case in our patients, perhaps in relation to preoperative beta and calcium channel blockers.
It is not possible to exclude hypovolaemia as a cause of increased vascular resistance and decreased cardiac index as circulating blood volume was not measured. However, there was no difference in bleeding, fluid volume administered, or right atrial pressures between groups. It seems reasonable, therefore, to assume that the observed decrease of cardiac index following sternotomy was due, at least in part, to cardiac depression caused by the inhala-tional agents. This agrees with the observation that cardiac index did not decrease in the fentanyl group.
The second difference between our study and previous reports is that our patients failed to increase cardiac index in compensation for decreased resistance following cardiopulmonary bypass. Systemic vascular resistance is known to decrease during and immediately after cardiopulmonary bypass [23] [24] [25] [26] , mostly due to decreased blood viscosity from haemodilution 26 . Patients with normal ventricles compensate for this decreased resistance by increasing cardiac output 25, 26 , thus maintaining arterial blood pressure. Our patients did in fact present decreased resistance following bypass, but they failed to increase cardiac index regardless of the anaesthesia technique. This was most likely due to diminished ventricular reserve, and it agrees with experimental data showing that normal animals increase cardiac output when subjected to normovolaemic haemodilution, while those with decreased cardiac contractility fail to do so 27 .
It is not possible from this data, nor was it the objective of the study, to infer clinical superiority for any of the agents in terms of outcome. There is already enough evidence that the choice of primary anaesthetic does not influence outcome in terms of mortality or major morbidity [2] [3] [4] . Also, the number of patients studied is far too small for this type of inference. Furthermore, the anaesthetic management used for this protocol differs from the current technique for patients with diminished ventricular function. Nevertheless, we submit that these results are clinically relevant, in that they provide information not previously available regarding the comparative effects of these anaesthetic agents in this particular group of patients.
